The importance of anti-fibrotic drugs as first-line therapy in patients with arrhythmogenic right ventricular dysplasia

dc.authoridÇinier, Göksel/0000-0001-5064-1816
dc.authoridTAYLAN, GOKAY/0000-0002-7015-4537
dc.authorwosidÇinier, Göksel/Y-1715-2019
dc.authorwosidTAYLAN, GOKAY/HJZ-4693-2023
dc.contributor.authorAksit, Ercan
dc.contributor.authorKucuk, Ugur
dc.contributor.authorTaylan, Gokay
dc.contributor.authorCinier, Goksel
dc.contributor.authorKarabay, Can Yucel
dc.contributor.authorAkgun, Taylan
dc.date.accessioned2024-06-12T10:51:58Z
dc.date.available2024-06-12T10:51:58Z
dc.date.issued2022
dc.departmentTrakya Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.1016/j.ijcard.2022.01.025
dc.identifier.endpage53en_US
dc.identifier.issn0167-5273
dc.identifier.issn1874-1754
dc.identifier.pmid35051491en_US
dc.identifier.scopus2-s2.0-85126301466en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage53en_US
dc.identifier.urihttps://doi.org/10.1016/j.ijcard.2022.01.025
dc.identifier.urihttps://hdl.handle.net/20.500.14551/18552
dc.identifier.volume353en_US
dc.identifier.wosWOS:000784330500012en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Ireland Ltden_US
dc.relation.ispartofInternational Journal Of Cardiologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnti-Fibrotic Drugsen_US
dc.subjectArrhythmogenic Cardiomyopathyen_US
dc.subjectCardiac Fibrosisen_US
dc.subjectRemodelingen_US
dc.titleThe importance of anti-fibrotic drugs as first-line therapy in patients with arrhythmogenic right ventricular dysplasiaen_US
dc.typeLetteren_US

Dosyalar